IntoCell Inc
KOSDAQ:287840
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
IntoCell Inc
KOSDAQ:287840
|
KR |
|
L
|
Lisgrafica Impressao e Artes Graficas SA
ELI:LIG
|
PT |
|
Catenae Innovation PLC
F:NZS0
|
UK |
|
Rainbow Rare Earths Ltd
LSE:RBW
|
GG |
|
I
|
Incross Co Ltd
KOSDAQ:216050
|
KR |
|
T
|
Tonami Holdings Co Ltd
TSE:9070
|
JP |
|
ME Group International PLC
LSE:MEGP
|
UK |
|
C
|
Chashma Sugar Mills Ltd
KAR:CHAS
|
PK |
|
M
|
Mental Health Technologies Co Ltd
TSE:9218
|
JP |
|
DCD Media PLC
LSE:DCD
|
UK |
|
C
|
Comtrend Corp
TPEX:8089
|
TW |
|
A
|
Aiit One Co Ltd
KOSDAQ:230980
|
KR |
|
D
|
Daiichi Commodities Co Ltd
TSE:8746
|
JP |
|
Gallant Venture Ltd
SGX:5IG
|
SG |
|
O
|
Open Orphan PLC
LSE:ORPH
|
UK |
Bankruptcy Probability
IntoCell Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
IntoCell Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
I
|
IntoCell Inc
KOSDAQ:287840
|
320.7B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
439.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
225.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
168.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
133.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
66.7B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
IntoCell Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, IntoCell Inc has total debt of 10.2B KRW. This includes both short-term (0 KRW) and long-term (10.2B KRW) debt.
You can find a full breakdown on its Balance Sheet.
